Inflammation News and Research

RSS

Psoriasis vs. atopic dermatitis: New study reveals surprising inflammatory differences in age-specific groups

The hematological parameters and serum biomarkers of inflammation and immunity in patients with atopic dermatitis and psoriasis.

12 Sep 2023

Is exposure to infections or autoimmune diseases associated with dementia incidence?

The relationships between hospital-identified infections, autoimmune diseases, and the onset of dementia.

12 Sep 2023

Research sheds light on the role of lipidome in human physiology

The sequencing of the human genome promised a revolution in medicine, but scientists soon realized that a genetic blueprint alone does not show the body in action.

11 Sep 2023

Buck Institute receives $3.5 million federal grant to lead clinical trial of ketone intervention in older adults

The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition of vulnerability which develops following age-related decline in multiple physiological systems.

11 Sep 2023

CPAP use reduces risk of death from cardiovascular disease in sleep apnea patients

People suffering with obstructive sleep apnoea (OSA) can reduce their risk of dying from cardiovascular disease if they use a continuous positive airway pressure (CPAP) machine at night, according to research presented at the European Respiratory Society International Congress in Milan, Italy.

11 Sep 2023

Emulsifiers and heart health: a prospective cohort study reveals associations

In a recent study published in BMJ, researchers examined the relationships between the intake of food emulsifiers and cardiovascular disease (CVD) risk.

11 Sep 2023

PI3K pathway rewiring drives prostate cancer growth

Experts in cell signaling at the Babraham Institute have identified how prostate cancer cells achieve cell growth free from the usual growth cues and regulators.

11 Sep 2023

Exploring the anti-cancer potential of dark tea

The potential of dark tea in cancer prevention and management.

11 Sep 2023

Color of the phlegm can indicate degree of lung inflammation in patients with bronchiectasis

The color of the phlegm from patients with the lung disease bronchiectasis can indicate the degree of inflammation in their lungs and predict their future outcomes, according to new research presented at the European Respiratory Society International Congress in Milan, Italy.

11 Sep 2023

Elite athletes bounce back strong: No long-term heart risks after COVID-19 recovery

The study finds that elite athletes who recovered from COVID-19 did not experience long-term negative effects on their cardiac health, allowing for the successful resumption of high-level sports. The findings also suggest that proper screening and medical counseling can pave the way for safe returns to sports post-COVID-19.

10 Sep 2023

Is DNA methylation the missing link in diagnosing and treating psoriasis and psoriatic arthritis?

Researchers across Europe have delved into the DNA methylation patterns in CD4+ T-cells of psoriasis and psoriatic arthritis (PsA) patients, unveiling potential new biomarkers for these conditions. Their study suggests that these unique profiles could serve as both diagnostic and prognostic tools, although further validation is needed for real-world clinical application.

10 Sep 2023

Study could pave the way to new treatments for people with compromised immune systems

New research led by Queen’s University Belfast has made a breakthrough in the field of microbiology, which could lead to the development of new treatments for people with compromised immune systems, such as those with cystic fibrosis.

9 Sep 2023

Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal

Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced acceptance of a publication, “Nasal Administration of anti-CD3 monoclonal antibody (mAb) ameliorates disease in a mouse model of Alzheimer’s disease”, in the preeminent journal, Proceedings of the National Academy of Sciences (PNAS), that supports foralumab’s mechanism as a potential treatment for Alzheimer’s disease (AD), a difficult-to-treat neuroinflammatory disease.

9 Sep 2023

Inflammation News and Research

Psoriasis vs. atopic dermatitis: New study reveals surprising inflammatory differences in age-specific groups

Is exposure to infections or autoimmune diseases associated with dementia incidence?

Research sheds light on the role of lipidome in human physiology

Buck Institute receives $3.5 million federal grant to lead clinical trial of ketone intervention in older adults

CPAP use reduces risk of death from cardiovascular disease in sleep apnea patients

Emulsifiers and heart health: a prospective cohort study reveals associations

PI3K pathway rewiring drives prostate cancer growth

Exploring the anti-cancer potential of dark tea

Color of the phlegm can indicate degree of lung inflammation in patients with bronchiectasis

Elite athletes bounce back strong: No long-term heart risks after COVID-19 recovery

Is DNA methylation the missing link in diagnosing and treating psoriasis and psoriatic arthritis?

Study could pave the way to new treatments for people with compromised immune systems

Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal

Implantable sensor provides advanced warning of kidney transplant failure in rats

Annual NHS flu vaccination program for children is getting underway

Phase I trial of senolytic therapy shows promise in Alzheimer's disease

Unraveling the relationship between obesity-related metabolic dysfunction and endotrophin

Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Researchers develop first electronic device for continuously monitoring health of transplanted organs

A subset of CD8+ T cells can play a protective role against Alzheimer’s disease pathogenesis

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News